New Glaritus Injection

New Glaritus Injection – Insulin Glargine 100 IU/mL for Diabetes Management

New Glaritus Injection contains Insulin Glargine 100 IU/mL, a long-acting basal insulin used to improve blood sugar control in adults and children with Type 1 and Type 2 diabetes mellitus. It provides a steady release of insulin over approximately 24 hours, helping maintain consistent blood glucose levels throughout the day and night. New Glaritus Injection helps the body’s cells absorb glucose from the bloodstream while reducing glucose production by the liver. It may be prescribed alone or in combination with rapid-acting insulin or oral antidiabetic medications, depending on your treatment plan. Maintaining good blood sugar control can help reduce the risk of diabetes-related complications affecting the eyes, kidneys, nerves, and heart. Use New Glaritus Injection exactly as prescribed by your healthcare professional. Regular blood glucose monitoring, a balanced diet, and physical activity are important parts of effective diabetes management.

Key Features

• Contains Insulin Glargine 100 IU/mL: A long-acting basal insulin for daily blood sugar control.
• 24-Hour Blood Glucose Control: Provides a steady insulin level throughout the day.
• Suitable for Type 1 & Type 2 Diabetes: Helps maintain stable blood glucose levels.
• Once-Daily Administration: Designed for convenient daily dosing.
• Supports Long-Term Diabetes Management: Helps reduce the risk of diabetes-related complications when used as directed.

Active Ingredient

• Insulin Glargine 100 IU/mL: A long-acting insulin analogue that helps regulate blood glucose levels.

How to Use

• Use only as prescribed by your healthcare provider.
• Administer as a subcutaneous injection into the abdomen, thigh, or upper arm.
• Rotate injection sites to reduce the risk of skin changes.
• Inject at the same time each day for consistent blood sugar control.
• Do not mix or dilute with other insulins unless instructed by your doctor.

Precautions

• Use only under medical supervision.
• Monitor your blood glucose levels regularly during treatment.
• Inform your doctor if you have kidney disease, liver disease, or other medical conditions.
• Do not use if the solution appears cloudy, colored, or contains particles.
• Keep out of reach of children.

Warning

• Common side effects may include low blood sugar (hypoglycemia), injection-site reactions, weight gain, or swelling.
• Seek immediate medical attention if you experience severe hypoglycemia or signs of a serious allergic reaction.
• Do not change your dose or discontinue treatment without consulting your healthcare provider.
• Always carry a fast-acting source of glucose in case of low blood sugar.

Storage

• Store refrigerated at 2°C to 8°C.
• Do not freeze the injection.
• Protect from direct sunlight and excessive heat.
• Keep in the original packaging until ready to use.

Legal Disclaimer: New Glaritus Injection is a prescription medication intended for the management of diabetes mellitus. Use only under the supervision of a qualified healthcare professional. This information is provided for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.